Adjuvant TRastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy in HER2-positive gastric or gastroesophageal cancer patients with persistence of minimal residual... by Vincenzo Nasca, Francesca Bergamo, Luisa Foltran, Lorenzo Antonuzzo, Katia Bencardino, Emanuela Dell’Aquila, Salvatore Corallo, Andrea Spallanzani, Oronzo Brunetti, Daniele Spada, Stefano Tamberi, Chiara Alessandra Cella, Antonio Avallone, Lorenzo Fornaro, Samantha Di Donato, Antonia Strippoli, Alberto Puccini, Emiliano Tamburini, Federica Palermo, Federica Morano, Filippo Pietrantonio, Alessandra Raimondi

Get full text

Correction to “New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe” [The Lancet Regional Health – Europe, volume 50, Ma... by Lorenza Rimassa, Angela Lamarca, Grainne M. O'Kane, Julien Edeline, Mairéad G. McNamara, Arndt Vogel, Matteo Fassan, Alejandro Forner, Timothy Kendall, Jorge Adeva, Andrea Casadei-Gardini, Lorenzo Fornaro, Antoine Hollebecque, Maeve A. Lowery, Teresa Macarulla, David Malka, Elene Mariamidze, Monica Niger, Anu Ustav, John Bridgewater, Rocio I.R. Macias, Chiara Braconi

Get full text